The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Bridge Project Events 2014

Symposium: Targeting Mutant IDH1 in Malignant Gliomas

May 22, 2014 Bridge to Success Targeting Mutant IDH1 in Malignant Gliomas, a collaboration between Matthew Vander Heiden of the Koch Institute, William Kaelin of the Dana-Farber Cancer Institute, and Daniel Cahill of Massachusetts General Hospital